Rosacea Treatment Market Scope
The global Rosacea Treatment market is expected to boost the global market due to increasing concern related to the skin treatments and availability of skin treatments. Rosacea is a chronic, inflammatory skin condition that is characterized by redness on the skin. Rosacea is a common inflammatory skin disorder that can seriously impair quality of life. Treatment starts with general measures which include gentle skin cleansing, photoprotection, and avoidance of exacerbating factors such as changes in temperature, ultraviolet light, stress, alcohol, and some foods. The adoption of superior technologies and the rise in consumer awareness and disposable income are major propellers across the globe.
The market study is being classified by Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea and Phymatous Rosacea) and major geographies with country level break-up.
Already existing key players are partnering to enhance their global footprint. At the same time, companies are increasing their R&D investments to identify better treatments for rosacea. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Rosacea Treatment market throughout the predicted period.
Allergan Plc (Ireland), Bayer Schering AG (Germany), Bausch Health Companies Inc. (Canada), Nestlé S.A. (Switzerland), Sol-Gel Technologies (Israel), Foamix Pharmaceuticals (Israel), Merck & Co., Inc (United States), PruGen Pharmaceuticals (United States), AbbVie Inc (United States) and Croda International Plc (United Kingdom) are some of the key players profiled in the study.
AdvanceMarketAnalytics has segmented the market of Global Rosacea Treatment market by Type, Application and Region.
On the basis of geography, the market of Rosacea Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.
Market Leaders and their expansionary development strategies
On 6th February 2020, Foamix Pharmaceuticals Ltd. (“Foamix” or the “Company”), a specialty pharmaceutical company, announced today the publication of the Company’s Phase 3 studies FX2016-11 and FX2016-12 (Studies 11 & 12) in the Journal of the American Academy of Dermatology (JAAD). and On 22nd December 2019, Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for IDP-123 (tazarotene 0.045%) Lotion with a PDUFA action date of Dec. 22, 2019. If approved, IDP-123 will be the first tazarotene acne treatment available in a lotion form.
On 17th October 2019, Foamix Pharmaceuticals Ltd., a clinical-stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for FMX103 (minocycline topical foam 1.5%) topical foam.
- High Demand due to Government Initiatives and Investments in the Treatment
- The Rapid Increase in the Availability of Generic Medicines for Rosacea
- The Growing Demand due to Advanced Formulations
- Rising Aawaewreness about Rosacea and Its Available Therapeutics
- Ongoing Research and Development of Advanced Formulations for Treatment of Different Types of Rosacea and Acne
- Off-label usage of Medicines for Rosacea
- Multiple Patent Expiries Bring a Significant Number of Generic Products
Key Target AudienceRosacea Treatment Providers, Government Regulatory Bodies, Private Research Organizations, Government Research Organizations and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase